Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 370,600 | 417,300 | 271,500 | 265,300 | 256,100 |
| Receivables | 1,286,700 | 1,277,200 | 1,204,800 | 1,222,400 | 1,195,400 |
| Inventories | 863,400 | 843,400 | 788,700 | 718,300 | 772,800 |
| Other current assets | 295,200 | 297,000 | 300,000 | 290,500 | 250,600 |
| TOTAL | $2,815,900 | $2,834,900 | $2,565,000 | $2,496,500 | $2,474,900 |
| Non-Current Assets | |||||
| PPE Net | 2,529,500 | 2,502,700 | 2,495,200 | 2,542,200 | 2,502,400 |
| Intangibles | 2,579,800 | 2,533,900 | 1,884,900 | 1,897,000 | 1,880,600 |
| Other Non-Current Assets | 564,400 | 558,900 | 556,000 | 543,100 | 548,100 |
| TOTAL | $5,673,700 | $5,595,500 | $4,936,100 | $4,982,300 | $4,931,100 |
| Total Assets | $8,489,600 | $8,430,400 | $7,501,100 | $7,478,800 | $7,406,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 414,700 | 633,300 | 314,900 | 314,400 | 403,800 |
| Accounts payable and accrued liabilities | 784,600 | 758,400 | 740,200 | 753,600 | 687,800 |
| TOTAL | $2,631,500 | $2,641,000 | $2,542,800 | $2,445,400 | $2,419,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,120,700 | 3,262,400 | 2,687,300 | 2,684,900 | 2,731,900 |
| aiOther Non-Current Liabilities | 1,035,900 | 1,025,100 | 1,000,400 | 1,005,400 | 875,300 |
| TOTAL | $4,611,000 | $4,758,000 | $4,150,900 | $4,146,300 | $4,149,500 |
| Total Liabilities | $7,242,500 | $7,399,000 | $6,693,700 | $6,591,700 | $6,568,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,060,570 | 1,062,116 | 1,064,176 | 1,065,220 | 1,074,479 |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 8,077,000 | 7,876,800 | 7,514,200 | 7,433,000 | 7,201,300 |
| Other shareholders' equity | -2,149,000 | -2,235,200 | -2,190,800 | -2,197,900 | -2,161,400 |
| TOTAL | $1,247,100 | $1,031,400 | $807,400 | $887,100 | $837,200 |
| Total Liabilities And Equity | $8,489,600 | $8,430,400 | $7,501,100 | $7,478,800 | $7,406,000 |